%0 Journal Article
%T 肝细胞癌合并门静脉癌栓的治疗进展
Progress in the Treatment of Hepatocellular Carcinoma Complicated with Portal Vein Tumor Thrombus
%A 马佳敏
%A 樊海宁
%J Advances in Clinical Medicine
%P 6018-6023
%@ 2161-8720
%D 2021
%I Hans Publishing
%R 10.12677/ACM.2021.1112892
%X 肝细胞癌为临床常见的恶性肿瘤,其高度恶性及易于侵犯和转移的生物学特性,致使患者生存率极低,其中最常见也是临床最棘手的一种情况是肝细胞癌合并门静脉癌栓,通常这类患者病情进展迅速,其治愈率极低,因此这类患者死亡率极高,而生存率极低。现阶段随着医疗水平和科学技术进步,肝细胞癌的相关治疗取得了显著进展,对于肝细胞癌的治疗也是采用多学科综合治疗模式,对于各期肝癌患者制定个体化治疗方案,采用联合治疗疗法,最大化改善患者的生活治疗和生存率。本文将从现有的治疗方法论述其在肝细胞癌治疗过程中的应用。
Hepatocellular carcinoma is a common clinical malignant tumor. Its highly malignant and prone to invasion and metastasis biological characteristics result in extremely low patient survival rates. One of the most common and clinically difficult conditions is hepatocellular carcinoma complicated with portal vein cancer. Suppository usually progresses rapidly in such patients, and its cure rate is extremely low. Therefore, the mortality rate of such patients is extremely high, and the survival rate is extremely low. At this stage, with the advancement of medical level and science and technology, significant progress has been made in the treatment of hepatocellular carcinoma. The treatment of hepatocellular carcinoma also adopts a multidisciplinary comprehensive treatment model. Individualized treatment plans are developed for patients with liver cancer at various stages, and combined therapy is adopted to maximize the improvement of patients’ life treatment and survival rate. This article will discuss its application in the treatment of hepatocellular carcinoma from the existing treatment methods.
%K 肝细胞癌,门静脉癌栓,多学科治疗
Hepatocellular Carcinoma
%K Portal Vein Tumor Thrombus
%K Multimodality Treatment
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=47535